Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature

C Chatre, F Roubille, H Vernhet, C Jorgensen, YM Pers - Drug safety, 2018 - Springer
Introduction Chloroquine and hydroxychloroquine are widely used in the long-term
treatment of connective tissue disease and usually considered safe. However, chloroquine …

[HTML][HTML] Immunology of COVID-19: current state of the science

N Vabret, GJ Britton, C Gruber, S Hegde, J Kim… - Immunity, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

AH De Wilde, D Jochmans, CC Posthuma… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Coronaviruses can cause respiratory and enteric disease in a wide variety of human and
animal hosts. The 2003 outbreak of severe acute respiratory syndrome (SARS) first …

[HTML][HTML] Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents

C Verbaanderd, H Maes, MB Schaaf… - …, 2017 - ncbi.nlm.nih.gov
Chloroquine (CQ) and hydroxychloroquine (HCQ) are well-known 4-aminoquinoline
antimalarial agents. Scientific evidence also supports the use of CQ and HCQ in the …

Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms

PMP Ferreira, RWR de Sousa… - Pharmacological …, 2021 - Elsevier
Chloroquine (CQ) and hydroxychloroquine (HCQ) are the most common drugs used to
relieve acute and chronic inflammatory diseases. In this article, we present a review about …

Chloroquine against malaria, cancers and viral diseases

W Zhou, H Wang, Y Yang, ZS Chen, C Zou… - Drug Discovery …, 2020 - Elsevier
Highlights•Chloroquine is used for anti-malaria, anti-cancer and anti-virus treatment.•The
efficacy of hydroxychloroquine against COVID-19 is controversial.•Several quinoline …

[HTML][HTML] Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies

J Dyall, R Gross, J Kindrachuk, RF Johnson… - Drugs, 2017 - Springer
No specific antivirals are currently available for two emerging infectious diseases, Middle
East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). A …

Evaluation of Ebola virus inhibitors for drug repurposing

PB Madrid, RG Panchal, TK Warren… - ACS infectious …, 2015 - ACS Publications
A systematic screen of FDA-approved drugs was performed to identify compounds with in
vitro antiviral activities against Ebola virus (EBOV). Compounds active (> 50% viral inhibition …

[HTML][HTML] Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension

LK Zhang, Y Sun, H Zeng, Q Wang, X Jiang, WJ Shang… - Cell Discovery, 2020 - nature.com
Abstract The coronavirus disease (COVID-19) caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has now spread to> 200 countries posing a global …

Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders–A comprehensive systematic review and meta-analysis

R Jeppesen, RHB Christensen, EMJ Pedersen… - Brain, behavior, and …, 2020 - Elsevier
Objective Antipsychotic effects of immunomodulating drugs have been suggested; however,
a thorough, comprehensive meta-analysis on the effect and safety of anti-inflammatory add …